2.Expression of proteins in p53(Mdm2-p53-p21~(WAF/CIP1)) pathway in thyroid carcinoma
Shuwen PENG ; Jiannan HUANG ; Xiqing JI ; Xinhua SHENG ; Jinggang TANG ; Yinxi ZHANG
Chinese Archives of Otolaryngology-Head and Neck Surgery 2006;0(06):-
OBJECTIVE To investigate the significance of expression of p53, Mdm2 and p21WAF/ CIP1 proteins and their relationships. METHODS Pathological specimens from thyroid carcinoma, adjacent non-tumor thyroid tissues and thyroid benign lesions were examined for p53, Mdm2 and p21WAF/CIP1 proteins by tissue microarray technique and immunohistochemistry method. RESULTS The positive expression rate of p53, Mdm2 and p21WAF/CIP1 in thyroid carcinoma was 50.6 %(37/73), 63.0 %(47/73) and 38.4 %(28/73) respectively. The expression of p53 and Mdm2 increased(P
3.Prevention of deep venous thrombosis in postoperative patients with central nervous system tumors using graduated compression stocking
Shu-Qing YU ; Ji-Sheng WANG ; Nan JI ; Ke QIAN ; Jie TANG
Chinese Journal of Neuromedicine 2009;8(12):1259-1261
Objective To explore the validity of graduated compression stockings (GCS) in the prevention of deep vein thrombosis (DVT) in postoperative patients with central nervous system tumors. Methods Patients in experimental group (n=100) were given GCS since the first operative day until they can walk. Patients in control group (n=80) did not apply GCS treatment. Doppler studies of the lower extremities were routinely obtained before and 3 days after surgery. Results Three patients developed DVT in the experimental group with an incidence rate of 3%; while 21 patients appeared DVT in the control group with an incidence rate of 26% and 1 patient developed pulmonary embolism. The efficacy between the experimental group and the control group were significantly different (P<0.05). Conclusion GCS can effectively prevent the DVT in postoperative patients with central nervous system tumors.
4.Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus.
Hai XU ; Yi-Wei WANG ; Ying-Hua TANG ; Qi-Sheng ZHENG ; Ji-Bo HOU
Chinese Journal of Virology 2013;29(4):376-381
To construct a recombinant T7 phage expressing matrix protein 2 ectodomain (M2e) peptides of avian influenza A virus and test immunological and protective efficacy in the immunized SPF chickens. M2e gene sequence was obtained from Genbank and two copies of M2e gene were artificially synthesised, the M2e gene was then cloned into the T7 select 415-1b phage in the multiple cloning sites to construct the recombinant phage T7-M2e. The positive recombinant phage was identified by PCR and sequencing, and the expression of surface fusion protein was confirmed by SDS-PAGE and Western-blot. SPF chickens were subcutaneously injected with 1 X 10(10) pfu phage T7-M2e, sera samples were collected pre- and post-vaccination, and were tested for anti-M2e antibody by ELISA. The binding capacity of serum to virus was also examined by indirect immunofluorescence assay in virus- infected CEF. The immunized chickens were challenged with 200 EID50 of H9 type avian influenza virus and viral isolation rate was calculated to evaluate the immune protective efficacy. A recombinant T7 phage was obtained displaying M2e peptides of avian influenza A virus, and the fusion protein had favorable immunoreactivity. All chickens developed a certain amount of anti-M2e antibody which could specially bind to the viral particles. In addition, the protection efficacy of phage T7-M2e vaccine against H9 type avian influenza viruses was 4/5 (80%). These results indicate that the recombinant T7 phage displaying M2e peptides of avian influenza A virus has a great potential to be developed into a novel vaccine for the prevention of avian influenza infection.
Animals
;
Antibodies, Viral
;
blood
;
Bacteriophage T7
;
genetics
;
immunology
;
metabolism
;
Chickens
;
Enzyme-Linked Immunosorbent Assay
;
Gene Expression Regulation, Viral
;
Immunization
;
Influenza A virus
;
genetics
;
immunology
;
Influenza Vaccines
;
immunology
;
Influenza in Birds
;
immunology
;
metabolism
;
prevention & control
;
Peptides
;
genetics
;
immunology
;
metabolism
;
Polymerase Chain Reaction
;
Recombinant Fusion Proteins
;
Specific Pathogen-Free Organisms
;
Viral Matrix Proteins
;
genetics
;
immunology
;
metabolism
5.Co-detection of P21, P53 and HSP70 and their possible role in diagnosis of polycyclic aromatic hydrocarbons (PAHs)-related lung cancer.
Qiao-fa LU ; Ming BAI ; Huan-jing ZHANG ; Ji-chao LI ; Cheng-feng XIAO ; Sheng CHEN ; Tang-chun WU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2003;21(5):359-361
OBJECTIVETo explore the biomarkers of early diagnosis in patients with polycyclic aromatic hydrocarbons (PAHs)-related lung cancer for the application to detection of occupational lung cancer or related lung cancer.
METHODSWestern dot blotting was used to explore the expression of ras, p53 and heat stress protein 70 (HSP70) in 29 patients with PAHs-related lung cancer (LC), and 28 patients with non-cancerous pulmonary disease, and 30 healthy controls.
RESULTSThe positive detection rates of P21, P53, and HSP70 in LC group (58.62%, 34.48%, 41.38% respectively) were higher than those in non-cancerous pulmonary disease group (14.29%, 7.14%, 10.71% respectively, P < 0.01). The sensitivity of P21, P53 and HSP70 were 58.62%, 34.48% and 41.38% respectively, negative predictive value (NPV) were 68.42%, 78.05% and 63.04% respectively. The co-detection of the three proteins mentioned above produced a sensitivity of 82.76% with a NPV of 78.26% (P < 0.05). Of 18 cases of LC with negative cytology, 13 (72.22%) were found HSP21, P53 or HSP70 positive.
CONCLUSIONSCo-detection of the P21, P53, and HSP70 may be used as the screening marker for diagnosis of PAHs-related lung cancer, and may supplement the diagnostic value of conventional cytology.
Aged ; Biomarkers ; analysis ; Blotting, Western ; Case-Control Studies ; HSP70 Heat-Shock Proteins ; analysis ; Humans ; Lung Neoplasms ; chemically induced ; metabolism ; pathology ; Middle Aged ; Occupational Exposure ; Polycyclic Aromatic Hydrocarbons ; poisoning ; Proto-Oncogene Proteins p21(ras) ; analysis ; Tumor Suppressor Protein p53 ; analysis
6.Laparoscopic treatment of traumatic iliopsoas hematoma.
Jue-hua JING ; Jun QIAN ; Da-sheng TIAN ; Ji-sen ZHANG ; Lei CHEN ; Jian TANG
Chinese Medical Journal 2013;126(4):795-797
Adolescent
;
Hematoma
;
diagnosis
;
surgery
;
Humans
;
Laparoscopy
;
methods
;
Magnetic Resonance Imaging
;
Male
7.Exploration of the Essence of "Endogenous Turbidity" in Chinese Medicine.
Xin-rong FAN ; Nong TANG ; Yun-xi JI ; Yao-zhong ZHANG ; Li JIANG ; Gui-hua HUANG ; Sheng XIE ; Liu-mei LI ; Chun-hui SONG ; Jiang-hong LING
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(8):1011-1014
The essence of endogenous turbidity in Chinese medicine (CM) is different from cream, fat, phlegm, retention, damp, toxicity, and stasis. Along with the development of modern scientific technologies and biology, researches on the essence of endogenous turbidity should keep pace with the time. Its material bases should be defined and new connotation endowed at the microscopic level. The essence of turbidity lies in abnormal functions of zang-fu organs. Sugar, fat, protein, and other nutrient substances cannot be properly decomposed, but into semi-finished products or intermediate metabolites. They are inactive and cannot participate in normal material syntheses and decomposition. They cannot be transformed to energy metabolism, but also cannot be synthesized as executive functioning of active proteins. If they cannot be degraded by autophagy-lysosome or ubiquitin-prosome into glucose, fatty acids, amino acids, and other basic nutrients to be used again, they will accumulate inside the human body and become endogenous turbidity. Therefore, endogenous turbidity is different from final metabolites such as urea, carbon dioxide, etc., which can transform vital qi. How to improve the function of zang-fu organs, enhance its degradation by autophagy-lysosome or ubiquitin-prosome is of great significance in normal operating of zang-fu organs and preventing the emergence and progress of related diseases.
Autophagy
;
Humans
;
Medicine, Chinese Traditional
;
Proteasome Endopeptidase Complex
8.Association of transcription factor FOXP3 gene polymorphism with genetic susceptibility to systematic lupus erythematosus in Guangxi Zhuang population.
Yan LAN ; Xiu-sheng TANG ; Jun QIN ; Jie WU ; Ji-min QIN
Chinese Journal of Medical Genetics 2010;27(4):433-436
OBJECTIVETo investigate the association of single nucleotide polymorphisms(SNP) of FOXP3 gene with susceptibility to systematic lupus erythematosus (SLE) in Chinese Zhuang population.
METHODSAuthor analyzed the -2383 C/T and -3281 C/A two SNPs of the FOXP3 gene promoter in 120 patients with SLE and 160 age and sex matched controls in a Chinese Zhuang population, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) strategy and DNA sequencing.
RESULTSThe distribution of the FOXP3 gene -3281 C/A polymorphism was not different between the two groups. However, the FOXP3 gene -2383 C/T polymorphism was significantly different (P<0.05) between the two groups. The relative risk of suffering from SLE of -2383T allele carriers was 1.715 times of the -2383C allele carriers (OR=1.715, 95%CI: 1.165-2.525). Consistent with the results of the genotyping analyses, the FOXP3 -2383T/-3281A haplotype frequency in patients with SLE was significantly higher than that in controls (P<0.05). The -2383T/-3281A allele was associated with a significantly increased risk of SLE (OR=2.196, 95%CI: 1.165-4.142).
CONCLUSIONThe FOXP3 gene -2383C/T polymorphism is associated with SLE, and the -2383T allele is risk factor for SLE in the population studied.
Alleles ; Asian Continental Ancestry Group ; ethnology ; China ; Forkhead Transcription Factors ; genetics ; Gene Frequency ; Genetic Predisposition to Disease ; genetics ; Genotype ; Haplotypes ; Humans ; Lupus Erythematosus, Systemic ; genetics ; Polymorphism, Genetic ; Polymorphism, Restriction Fragment Length ; Polymorphism, Single Nucleotide ; genetics ; Population Groups ; ethnology ; Risk Factors ; Transcription Factors ; genetics
9.Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease.
Wei-Ju LI ; Hong-Yin ZHANG ; Cheng-Long MIAO ; Ri-Bo TANG ; Xin DU ; Ji-Hui SHI ; Chang-Sheng MA
Chinese Medical Journal 2011;124(10):1569-1572
OBJECTIVETobacco smoking results in increased platelet aggregability, which suggests that low-dose aspirin used in common clinical practice may not effectively inhibit platelet activity in smokers with coronary heart disease (CHD). This review was performed to assess the effect of aspirin on platelet aggregation in patients with CHD.
DATA SOURCESWe performed an electronic literature search of MEDLINE (starting from the beginning to March 15, 2009) using the term "smoking" or "tobacco" paired with the following: "platelet", "aspirin" or "coronary heart disease".
STUDY SELECTIONWe looked for review articles regarding the effect of tobacco smoking on platelet activity and on the anti-platelet efficacy of aspirin in healthy people and patients with CHD. The search was limited in "core clinical journal". In total, 1321 relevant articles were retrieved, and 36 articles were ultimately cited.
RESULTSTobacco smoking results in increased platelet aggregability, which can be inhibited by low-dose aspirin in the healthy population. However, in patients with CHD, the increased platelet aggregability can not be effectively inhibited by the same low-dose of aspirin. A recent study indicated that clopidogrel or an increased dose of aspirin can effectively inhibit the increased platelet aggregability induced by tobacco smoking in patients with CHD.
CONCLUSIONSIt is important for patients with CHD to quit smoking. For the current smoker, it may be necessary to take larger doses of aspirin than normal or take an adenosine diphosphate receptor inhibitor along with aspirin to effectively inhibit the increased platelet activity.
Aspirin ; therapeutic use ; Coronary Disease ; drug therapy ; Drug Interactions ; Humans ; Platelet Aggregation Inhibitors ; therapeutic use ; Smoking ; adverse effects
10.Molecular Mechanism and Therapeutic Exploration of CD36 in Breast Cancer
Shengqiao FU ; Qian JI ; Xinyu SUN ; Xi PU ; Yuting WU ; Haowei TANG ; Wanying SHENG ; Xu WANG
Cancer Research on Prevention and Treatment 2024;51(5):380-385
Breast cancer is the most diagnosed cancer in women worldwide and the leading cause of most cancer-related deaths, posing a serious threat to women′s health worldwide. At present, although the prognosis of some patients with breast cancer has improved, the emergence of drug resistance and the metastasis and recurrence of breast cancer are still the main reasons for poor prognosis. CD36 is a multiligand transmembrane glycoprotein expressed on various cell types. In recent years, studies have confirmed that CD36 can reshape the lipid metabolism of cancer cells; promote the differentiation of tumor-related macrophages into M2 type and recruitment into tumor tissues; regulate the function of Treg cells, CD8+ T cells, DCs, and other immune cells, and thus promote tumor development. In addition, CD36 is also associated with breast cancer stem cells, metastasis-initiating cells, and breast drug resistant cells. Therefore, CD36 could be an important potential therapeutic target for breast cancer.